Donepezil in Alzheimer's disease and vascular dementia
Damulin, I.V.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(7): 71-75
2013
ISSN/ISBN: 1997-7298 PMID: 24073452 Document Number: 670225
Document emailed within 1 workday
Related Documents
Jindahra, P.; Vejjajiva, A.; Witoonpanich, R.; Sirisriro, R.; Sritara, C.; Pulkes, T. 2004: Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report) Journal of the Medical Association of Thailand 87(10): 1176-1181Rogers, S.L.; Doody, R.S.; Mohs, R.C.; Friedhoff, L.T. 1998: Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group Archives of Internal Medicine 158(9): 1021-1031
Higashiyama, S.; Kawabe, J.; Hashimoto, H.; Akiyama, H.; Kawamura, E.; Torii, K.; Inoue, K.; Kiriike, N.; Shiomi, S.; Inoue, Y. 2006: 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy Osaka City Medical Journal 52(2): 55-62
Higashiyama, S.; Kawabe, J.; Hashimoto, H.; Akiyama, H.; Kawamura, E.; Torii, K.; Inoue, K.; Kiriike, N.; Shiomi, S.; Inoue, Y. 2006: 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy Osaka City Medical Journal 52(2): 55-62
Tavares, A.R.; de Melo, Aéia.C.; Sternberg, C. 2010: Cancer linked to Alzheimer disease but not vascular dementia Neurology 75(13): 1215-6; author reply 1216
Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. 1997: A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. the Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11(Suppl 2): S40-S44
Senanarong, V.; Poungvarin, N.; Phanthumchinda, K.; Thavichachart, N.; Chankrachang, S.; Praditsuwan, R.; Nidhinandana, S. 2009: Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients Journal of the Medical Association of Thailand 92(Suppl 2): S12-S18
Wettstein, A. 2001: Differentiating between Alzheimer disease and vascular dementia? Currently no longer significant Fortschritte der Medizin. Originalien 119(3-4): 139-140
Ble, A.; Ranzini, M.; Zurlo, A.; Menozzi, L.; Atti, A.R.; Munari, M.R.; Volpato, S.; Scaramelli, G.; Fellin, R.; Zuliani, G. 2006: Leukoaraiosis is associated with functional impairment in older patients with Alzheimer's disease but not vascular dementia Journal of Nutrition Health and Aging 10(1): 31-35
Lang, C. 1990: Diagnosis of Alzheimer's dementia. 2. Severity--differentiation from vascular forms of dementia (Hachinski Score) Fortschritte der Medizin 108(34): 657-659
1997: Donepezil (Aricept) for Alzheimer's disease Medical Letter on Drugs and Therapeutics 39(1002): 53-54
Geldmacher, D.S. 1997: Donepezil (Aricept) therapy for Alzheimer's disease Comprehensive Therapy 23(7): 492-493
Glasø, M.; Nordbø, G.; Diep, L.; Bøhmer, T. 2004: Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease Journal of Nutrition Health and Aging 8(5): 407-413
Sánchez Morillo, J.; Demartini Ferrari, A.; Roca de Togores López, A. 2003: Interaction of donepezil and muscular blockers in Alzheimer's disease Revista Espanola de Anestesiologia y Reanimacion 50(2): 97-100
Lipczyńska-Łojkowska, W.; Ryglewicz, D.; Jedrzejczak, T.; Jakubowska, T.; Kotapka-Minc, S.ła.; Sienkiewicz-Jarosz, H.; Bochyńska, A. 2004: The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia: follow-up for 2 years Neurologia i Neurochirurgia Polska 38(6): 471-481
Robert, P.H.; Gokalsing, E.; Bertogliati, C. 1999: Cholinergic hypothesis and Alzheimer's disease: the place of donepezil (Aricept) L'Encephale 25(Special Issue 5): 23-27; Discussion: 28-29
Creţu, O.; Szalontay, A.S.; Chiriţă, R.; Chiriţă, V. 2008: Effect of memantine treatment on patients with moderate-to-severe Alzheimer's disease treated with donepezil Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 641-645
Henigsberg, N.; Kalember, P.; Hrabać, P.; Rados, M.; Bajs, M.; Rados, M.; Kovavić, Z.; Loncar, M.; Madzar, T. 2011: 1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease Collegium Antropologicum 35(Suppl 1): 159-162
McCusker, S.M.; Curran, M.D.; Dynan, K.B.; McCullagh, C.D.; Urquhart, D.D.; Middleton, D.; Patterson, C.C.; McIlroy, S.P.; Passmore, A.P. 2001: Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study Lancet 357(9254): 436-439
Tanović, A.; Alfaro, V. 2006: Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia Revista de Neurologia 42(10): 607-616